全文获取类型
收费全文 | 28458篇 |
免费 | 2687篇 |
国内免费 | 473篇 |
专业分类
耳鼻咽喉 | 187篇 |
儿科学 | 374篇 |
妇产科学 | 343篇 |
基础医学 | 2284篇 |
口腔科学 | 326篇 |
临床医学 | 2041篇 |
内科学 | 1582篇 |
皮肤病学 | 449篇 |
神经病学 | 252篇 |
特种医学 | 1091篇 |
外国民族医学 | 18篇 |
外科学 | 11639篇 |
综合类 | 3348篇 |
现状与发展 | 1篇 |
预防医学 | 796篇 |
眼科学 | 102篇 |
药学 | 1537篇 |
11篇 | |
中国医学 | 649篇 |
肿瘤学 | 4588篇 |
出版年
2024年 | 46篇 |
2023年 | 365篇 |
2022年 | 627篇 |
2021年 | 971篇 |
2020年 | 977篇 |
2019年 | 927篇 |
2018年 | 907篇 |
2017年 | 1045篇 |
2016年 | 987篇 |
2015年 | 1267篇 |
2014年 | 1876篇 |
2013年 | 1913篇 |
2012年 | 1691篇 |
2011年 | 1817篇 |
2010年 | 1622篇 |
2009年 | 1452篇 |
2008年 | 1560篇 |
2007年 | 1555篇 |
2006年 | 1409篇 |
2005年 | 1310篇 |
2004年 | 1161篇 |
2003年 | 936篇 |
2002年 | 763篇 |
2001年 | 672篇 |
2000年 | 435篇 |
1999年 | 334篇 |
1998年 | 412篇 |
1997年 | 345篇 |
1996年 | 287篇 |
1995年 | 231篇 |
1994年 | 195篇 |
1993年 | 168篇 |
1992年 | 148篇 |
1991年 | 132篇 |
1990年 | 93篇 |
1989年 | 112篇 |
1988年 | 107篇 |
1987年 | 101篇 |
1986年 | 87篇 |
1985年 | 106篇 |
1984年 | 78篇 |
1983年 | 69篇 |
1982年 | 77篇 |
1981年 | 65篇 |
1980年 | 59篇 |
1979年 | 24篇 |
1978年 | 24篇 |
1977年 | 26篇 |
1976年 | 20篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
TOMONORI KATO HIROYOSHI SUZUKI AKIRA KOMIYA TAKASHI IMAMOTO YUKIO NAYA TOYOFUSA TOBE TOMOHIKO ICHIKAWA 《International journal of urology》2006,13(7):915-919
AIM: The clinical significance of the urinary white blood cell (U-WBC) count and serum C-reactive protein (CRP) level was evaluated in an effort to improve the efficiency of prostate biopsies. METHODS: We enrolled 228 consecutive patients with serum prostate-specific antigen (PSA) ranging from 3.0 to 20.0 ng/mL, normal digital rectal examination findings, and who underwent prostate biopsies between January 2001 and August 2004. Of these, 157 patients had histologically confirmed benign prostatic disease and the remaining 71 patients had prostate cancer. Patients with a pretreatment U-WBC count < or =3 or >3/high power field were defined as non-pyuria and pyuria, respectively. The patients were also separated into two groups based on the serum CRP level prior to biopsy. Several clinical factors were compared among these subgroups. RESULTS: Inflammation was histologically detected at rates of 58.1% and 34.1% in the pyuria and non-pyuria groups, respectively (P = 0.0014). The rates of cancer detection were significantly lower in the pyuria, than in the non-pyuria group (P = 0.0384). The cancer detection rates did not significantly differ according to serum CRP levels prior to biopsy. CONCLUSION: The U-WBC count appears to be a reliable indicator of minute prostatic inflammation. The serum PSA level was elevated in patients with asymptomatic prostatitis. Counting U-WBC is a simple, convenient and non-invasive method that should be valuable part of routine urological examinations. 相似文献
34.
Nobumichi Takeuchi Hiroshi Shimada Koichiro Misuta Akira Nakano 《Journal of hepato-biliary-pancreatic sciences》1997,4(1):119-122
We surgically treated a patient with biliary stricture and portal vein occlusion, after operation for gastric cancer with lymphadenectomy along the hepatoduodenal ligament, that had led to choledochal stone formation and a dilatated parabiliary venous system. A 57-year-old man without hepatic dysfunction exhibited hepatic duct dilatation with choledochal stone on ultrasonography and percutaneous transhepatic cholangiography, respectively. Pharmacoportography revealed occlusion of the portal vein and dilatation of the parabiliary venous system. Of various preoperative imaging studies used, enhanced computed tomography was most useful for delineating the surgical anatomy of the hepatoduodenal ligament. Complete preservation of the dilatated vessels, which functioned as the main portal collateral pathway, resulted in a successful choledocho-jejunostomy, with an uneventful postoperative course. 相似文献
35.
中老年男性下尿路症状的流行病学调查 总被引:8,自引:3,他引:5
为了了解下尿路症状在中、老年男性中的流行情况,用附加了二个症状问题的SL问卷对871名52~74岁的男子作回顾性调查,对调查结果作了年龄分组分析。结果发现:平均IPSS总分为4.93分,无症状者为12.2%,轻症者为64.7%,中度症状者为19.6%,重症者为3.5%。夜尿者占72.3%,尿终滴沥占54.4%,而症状中分值>3分者尿终滴沥占25.6%,夜尿占14.6%,平均QOL为1.74,QOL为0~2、3、4~6的比例分别为52.7%、46.0%、1.3%。QOL与IPSS的相关性较好(r=0.62),与梗阻症状群的相关性(r=0.57)优于与刺激症状的相关性(r=0.44)。中重度症状者中有72.0%的人未进行治疗。 相似文献
36.
诱导型一氧化氮合酶与移植血管平滑肌细胞增生的关系 总被引:2,自引:0,他引:2
目的 探讨诱导型一氧化氮合酶 (iNOS)与移植血管平滑肌细胞增生的关系。方法 新西兰大白兔 15只随机分成 3组 ,建立双侧颈动脉间置移植颈外静脉的动物模型。高剂量组每日喂食L 精氨酸 (L Arg) 2 5 0mg/kg ,低剂量组每日喂食L Arg 12 5mg/kg ;对照组不喂食L Arg ,持续 2周。检测血浆和组织匀浆一氧化氮(NO)水平 ,移植血管iNOSmRNA表达。观察术后 3和 6周移植血管平滑肌细胞增生。结果 1.iNOS活性 :(1)血浆NO水平 :实验组血浆NO水平显著高于对照组 ,高剂量组血浆NO水平高于低剂量组 ;(2 )组织匀浆一氧化氮合酶 (NOS)活性 :实验组组织匀浆NOS活性显著高于对照组 ;(3)组织匀浆iNOSmRNA表达 :术后 3周实验组iNOSmRNA表达 ,对照组无表达 ;术后 6周实验组iNOSmRNA表达高于对照组 ,高剂量组高于低剂量组。 2 .移植血管平滑肌细胞形态学变化 :(1)SMA免疫组化染色 :实验组移植血管平滑肌细胞厚度低于对照组 ;术后 6周低剂量组移植血管平滑肌细胞厚度低于高剂量组 ;(2 )PCNA免疫组化染色 :术后 3周实验组平滑肌细胞增殖低于对照组 ;术后 6周低剂量组平滑肌细胞增殖低于对照组和高剂量组。结论 iNOS表达致体内NO水平增高可抑制移植血管平滑肌细胞增生 ;NO浓度与平滑肌细胞增生关系密切 相似文献
37.
经尿道前列腺电切气化术治疗前列腺增生568例报告 总被引:13,自引:0,他引:13
目的 :进一步探讨前列腺增生 (BPH)的有效手术新方法。方法 :采用经尿道前列腺电切术和气化术治疗BPH患者 5 6 8例。结果 :疗效满意 ,术后 3~ 6个月随访 ,国际前列腺症状评分 (IPSS) 8.5± 1.5分 ;最大尿流率 (Q max) 2 0 .5± 4 .5ml s,剩余尿量 2 9.1± 14 .2ml,未出现严重并发症。结论 :将电切和气化相结合行经尿道前列腺切除术是一种安全性高、并发症少、疗效确切的新手术方法 ,具有操作易掌握、出血少、速度快、安全可靠等优点。 相似文献
38.
Castleman disease is a rare disorder characterized by lymphoid hyperplasia which rarely manifests in children. We present 2 cases which highlight both histologic variants of this disease, and provide suggestions regarding workup and treatment with the goal of making practitioners aware of Castleman disease in the differential diagnosis of a child presenting with vague symptoms. 相似文献
39.
Loss of heterozygosity alterations associated with progesterone therapy in endometrial hyperplasia and adenocarcinoma 总被引:1,自引:0,他引:1
M. Yasuda S. Kotajima H. Kajiwara S. Takekoshi R. Y. Osamura T. Yoshitake† T. Muramatsu† T. Miyamoto† M. Murakami† & T. Shinozuka† 《International journal of gynecological cancer》2005,15(1):155-162
Loss of heterozygosity (LOH) was analyzed in four patients with endometrial hyperplasia (EH) with atypia (two patients) and without atypia (two patients) and in five patients with endometrial adenocarcinoma (EAC) to clarify the clinicopathologic relationship between genetic alterations and hormone therapy. Each patient was initially administered high-dose medroxyprogesterone acetate (MPA) as a uterine-sparing treatment. The five microsatellite markers used to analyze LOH were at chromosomal loci 8p22.1, 8p21, 8p21.3, 8p22, and 8p22. DNA was extracted from paraffin-embedded sections before, during, and after MPA therapy using laser capture microdissection. As a result, LOH was more frequently detected after MPA therapy (overall ratios were 16, 17, and 29% before, during, and after MPA therapy, respectively). LOH is more easily detected in EH loci than in EAC loci before MPA. For EAC, initial LOH detection on chromosome 8 may be related to an incomplete response to MPA, but negative LOH does not guarantee a favorable treatment outcome. For EH or atypical endometrial hyperplasia, it is unknown whether LOH alteration associated with MPA therapy is related to atypia of the disease. 相似文献
40.
Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer 总被引:3,自引:0,他引:3
TOYOAKI UCHIDA HIROSHI OHKUSA HIDEYUKI YAMASHITA SUNAO SHOJI YOSHIHIRO NAGATA TORU HYODO TAKEFUMI SATOH 《International journal of urology》2006,13(3):228-233
BACKGROUND: High-intensity focused ultrasound (HIFU) is a minimally invasive technique used in achieve coagulation necrosis. We evaluated biochemical disease-free survival rates, predictors of clinical outcome and morbidity in patients with localized prostate cancer treated with HIFU. METHODS: A total of 181 consecutive patients underwent HIFU with the use of Sonablate (Focus Surgery, Indianapolis, IN, USA). Biochemical recurrence was defined according to the criteria recommended by the American Society for Therapeutic Radiology and Oncology Consensus Panel. The median age and pretreatment prostate-specific antigen (PSA) level were 70 years (range 44-88) and 9.76 ng/mL (range 3.39-89.60). A total of 95 patients (52%) were treated with neoadjuvant hormones. The median follow-up period for all patients was 18.0 months (range 4-68). RESULTS: The biochemical disease-free survival rates at 1, 3 and 5 years in all patients were 84%, 80% and 78%, respectively. The biochemical disease-free survival rates at 3 years for patients with pretreatment PSA less than 10 ng/mL, 10.01-20.0 ng/mL and more than 20.0 ng/mL were 94%, 75% and 35%, respectively (P<0.0001). Multivariate analysis identified pretreatment PSA (P<0.0001) as a independent predictor of relapse. CONCLUSION: High-intensity focused ultrasound therapy appears to be a safe and efficacious minimally invasive therapy for patients with localized prostate cancer, especially those with a pretreatment PSA level less than 20 ng/mL. 相似文献